Stockhub

Zhejiang Starry Pharmaceutical Co.,Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

28 August 2022

  • curprev 15:3015:30, 28 August 2022 >Nick 736 bytes +736 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones p..."
Retrieved from "https://stockhub.co/research/Zhejiang_Starry_Pharmaceutical_Co.,Ltd."